Biochemical and genetic predictors of overall survival in patients with metastatic pancreatic cancer treated with capecitabine and nab-paclitaxel

Pancreatic cancer is a dismal disease with a mortality rate almost similar to its incidence rate. To date, there are neither validated predictive nor prognostic biomarkers for this lethal disease. Thus, the aim of the present study was to retrospectively investigate the capability of biochemical par...

Descripción completa

Detalles Bibliográficos
Autores principales: Bianconi, Daniela, Heller, Gerwin, Spies, Daniel, Herac, Merima, Gleiss, Andreas, Liebmann-Reindl, Sandra, Unseld, Matthias, Kieler, Markus, Scheithauer, Werner, Streubel, Berthold, Zielinski, Christoph C., Prager, Gerald W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501799/
https://www.ncbi.nlm.nih.gov/pubmed/28687745
http://dx.doi.org/10.1038/s41598-017-04743-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5501799/
https://www.ncbi.nlm.nih.gov/pubmed/28687745
http://dx.doi.org/10.1038/s41598-017-04743-0

Ejemplares similares